<div id="readability-page-1"><p>Exzeo Group, Inc. (NYSE:XZO - Get Free Report) has been assigned an average rating of &#34;Moderate Buy&#34; from the five analysts that are presently  covering the stock, MarketBeat reports. Two analysts have rated the stock with a hold rating and three have assigned  a buy rating to  the company. The average 1 year price objective among analysts that have issued a report on the stock in the last year is $26.00.</p><p>Several analysts recently commented on XZO shares. Citizens Jmp started coverage on Exzeo Group in a research report on Monday, December 1st. They issued a &#34;market outperform&#34; rating and a $27.00 price target on the stock. William Blair initiated coverage on shares of Exzeo Group in a research report on Monday, December 1st. They issued an &#34;outperform&#34; rating on the stock. Truist Financial assumed coverage on Exzeo Group in a research note on Monday, December 1st. They set a &#34;buy&#34; rating and a $25.00 target price for the company. Weiss Ratings started coverage on shares of Exzeo Group in a research note on Monday. They set a &#34;hold (c-)&#34; rating on the stock. Finally, Zacks Research raised shares of Exzeo Group to a &#34;hold&#34; rating in a report on Tuesday, December 2nd.</p><p><b>View Our Latest Report on XZO</b></p><h2>Exzeo Group Trading Down 12.7%</h2><p>Exzeo Group stock traded down $2.68 during mid-day trading on Tuesday, reaching $18.35. 276,677 shares of the company's stock were exchanged, compared to its average volume of 126,649. Exzeo Group has a twelve month low of $12.91 and a twelve month high of $24.60. The firm has a market capitalization of $1.67 billion and a P/E ratio of 73.40. The stock's fifty day simple moving average is $20.78. </p><p>Exzeo Group (NYSE:XZO - Get Free Report) last posted its quarterly earnings results on Wednesday, December 10th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.21 by $0.04. The company had revenue of $55.17 million during the quarter, compared to analyst estimates of $54.40 million. </p><h2>Insiders Place Their Bets</h2><p>In related news, CFO Suela Bulku acquired 10,020 shares of the company's stock in a transaction dated Thursday, December 18th. The stock was bought at an average price of $19.58 per share, with a total value of $196,191.60. Following the purchase, the chief financial officer directly owned 314,874 shares in the company, valued at $6,165,232.92. The trade was a 3.29% increase in their position. The purchase was disclosed in a legal filing with the Securities &amp; Exchange Commission, which is available at this link. Also, General Counsel Brook Armstrong Baker purchased 10,020 shares of the company's stock in a transaction that occurred on Thursday, December 18th. The shares were bought at an average cost of $19.58 per share, with a total value of $196,191.60. Following the transaction, the general counsel directly owned 248,026 shares of the company's stock, valued at $4,856,349.08. The trade was a 4.21% increase in their position. The disclosure for this purchase is available in the SEC filing. Over the last 90 days, insiders purchased 32,550 shares of company stock valued at $637,329. </p><h2>Institutional Investors Weigh In On Exzeo Group</h2><p>An institutional investor recently bought a new position in Exzeo Group stock. Jennison Associates LLC bought a new position in  Exzeo Group, Inc. (NYSE:XZO - Free Report) in the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 581,262 shares of the company's stock, valued at approximately $14,096,000. Jennison Associates LLC owned approximately 0.64% of Exzeo Group at the end of the most recent quarter. </p><h2>About Exzeo Group</h2> (Get Free Report)<p>Exzeo provides turnkey insurance technology and operations solutions to insurance carriers and their agents based on a proprietary platform of purpose-built software and data analytics applications that are specifically designed for the property and casualty, or P&amp;C, insurance ecosystem. Exzeo's Insurance-as-a-Service (IaaS) platform, which we refer to as the “Exzeo Platform,” currently includes nine highly configurable software and data analytics applications that are purpose-built to serve insurance companies and other customers in the insurance value chain.</p><h2>Featured Articles</h2><ul><li>Five stocks we like better than Exzeo Group</li><li>The day the gold market broke</li><li>Forget AI, This Will Be the Next Big Tech Breakthrough</li><li>Trump Planning to Use Public Law 63-43: Prepare Now</li><li>ALERT: Drop these 5 stocks before the market opens tomorrow!</li><li>Ticker Revealed: Pre-IPO Access to &#34;Next Elon Musk&#34; Company</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVhaTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="600" height="385" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/RatingsChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVhaTw"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.</em></p><h2>Should You Invest $1,000 in Exzeo Group Right Now?</h2><p>Before you consider Exzeo Group, you'll want to hear this.</p><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Exzeo Group wasn't on the list.</p><p>While Exzeo Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p><p>View The Five Stocks Here</p>                  </div>

<p>Exzeo Group, Inc. (NYSE:XZO) has received a consensus rating of "Moderate Buy" from five analysts, with two holding and three buying ratings. The average price target is $26.00. Recently, analysts from Citizens Jmp, William Blair, and Truist Financial initiated coverage with positive ratings. The stock is currently trading at $18.35, down 12.7%, with a market cap of $1.67 billion. Insiders have recently purchased shares, indicating confidence in the company. Exzeo provides insurance technology solutions through its proprietary platform.</p>

Exzeo Group, Inc. (NYSE:XZO) Given Consensus Recommendation of "Moderate Buy" by Brokerages